Adherence of Infusible Biologics During the Time of COVID-19 Among Patients With Inflammatory Bowel Disease: A Nationwide Veterans Affairs Cohort Study.

Authors:
Khan N; Patel D; Xie D; Pernes T; Lewis J and 1 more

Journal:
Gastroenterology

Publication Year: 2020

DOI:
10.1053/j.gastro.2020.06.044

PMCID:
PMC7305703

PMID:
32574622

Journal Information

Full Title: Gastroenterology

Abbreviation: Gastroenterology

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest These authors disclose the following: Nabeel Khan has received research funding from 10.13039/100004319Pfizer , Luitpold , and Takeda Pharmaceuticals . James Lewis has served as a consultant for Merck, AbbVie, Lilly, Janssen, Johnson & Johnson Consumer Inc, and Takeda; has served on Data Safety Monitoring Boards for Pfizer, Gilead, and UCB; and has received research support from Takeda and 10.13039/100010886Nestle Health Science . The remaining authors disclose no conflicts."

Evidence found in paper:

"Conflicts of interest These authors disclose the following: Nabeel Khan has received research funding from 10.13039/100004319Pfizer, Luitpold, and Takeda Pharmaceuticals. James Lewis has served as a consultant for Merck, AbbVie, Lilly, Janssen, Johnson & Johnson Consumer Inc, and Takeda; has served on Data Safety Monitoring Boards for Pfizer, Gilead, and UCB; and has received research support from Takeda and 10.13039/100010886Nestle Health Science. The remaining authors disclose no conflicts."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025